32 results about "Mother's milk" patented technology

The invention relates to a powder, such as an amino acid and/or protein powder that is optimized for human beings in the respect that its combined amino acid profile reflects the amino acid profile of human mother's milk protein. The invented powder, such as an amino acid and/or protein powder is suitable to be used as a nutrition supplement and relates also to tablets, capsules or pellets comprising said protein mixture, as well as food products comprising said protein mixture.

The invention relates to a liquid artificial milk feed, a production method and a feeding device, and the liquid artificial milk feed is characterized in that the formula comprises the following raw materials by weight percent: 4-6% of soy protein concentrate, 4-7% of beef extract, 1-3% of starch, 9-11% of whey powder, 4-7% of pure milk, 0.4-0.6% of calcium hydrogen phosphate, 0.2-0.4% of calciumcarbonate, 0.1-0.2% of common salt, 0.02-0.04% of compound vitamin, 0.1-0.3% of compound trace element, 0.01-0.03% of colistin, 0.01-0.02% of kitasamycin, 0.04-0.06% of bacillus subtilis and the balance of drinking water. The liquid artificial milk feed has the advantage of retarding a series of inadaptations of piglets in the aspects of emergency and a digestive system caused by direct transition from sow milk to powder material during delectation of the piglets. The product can not only meet the nutritional requirements for physiology, growth and development of the piglets, but also realize the scientific and safe transition from the liquid sow milk to the powder material.

A method and kit for the sequential early introduction to an infant of at least two allergens to decrease the infant's risk for developing allergies, the method involving administering an initial lower, exposure dose of a first allergen for a day or two, followed by administering a higher maintenance dose of the first allergen for several days, followed by administering the maintenance dose of the first allergen and an initial lower, exposure dose of a second allergen for a day or two, followed by administering the higher maintenance dose of the first allergen and a higher maintenance does of the second allergen for several days. The allergens can be provided in powdered protein form in premeasured pouches for addition to baby formula or to mother's milk. Alternatively, the allergens can already be provided in baby formula, or in other foods such as snack bars, cookies, or gels.

This invention provides compositions of oligosaccharides, their preparation, and their use to facilitate the growth of certain beneficial gut bacteria over other gut bacteria in a mammal in order to prevent gastrointestinal distress associated with a major change in gut microflora, such as that which occurs when an infant is weaned from its mother's milk to alternative food sources, or during the recovery of the gut microbiome after a course of oral antibiotics, hospitalization, therapy such as chemotherapy or radiation treatments, or conditions where a deficiency in dietary fiber is observed. Novel compositions of oligosaccharides, oligosaccharides and bacteria, foods comprising those compositions, and methods of preparation and use of those compositions are described.

The invention relates to a human milk oligosaccharide (HMO) for use in, a synthetic composition comprising an HMO for use in and a method for preventing or treating migraine in a human.

Provided is a technique that makes it possible to promote proliferation of probiotics having a low ability to assimilate human milk oligosaccharides (HMOs), in the presence of HMOs. Also provided is a nutritional composition containing bacteria belonging to Bifidobacterium bifidum, one or more types of probiotics having a low ability to assimilate human milk oligosaccharides, and human milk oligosaccharides. The nutritional composition according to the present technology may be suitably used for foods/drinks, medicines, quasi-drugs, feeds, and the like.

The invention relates to a powdered human milk fortifier comprising a protein component typically present in an amount ranging from 6 wt/wt % to 20 wt/wt % of the fortifier powder, and a fat component typically present in an amount of from about 0.1 wt/wt % to 10 wt/wt % of the fortifier powder and a carbohydrate component selected from the group of Lactose and Oligosaccharides present in the in an amount from 50 wt/wt % to 75 wt/wt % of the fortifier powder; a moisture in the powdered milk fortifier in present in quantity of about 1.5 wt/wt % to about 4.5 wt/wt % of the powdered human milk fortifier; nutrients in the powdered milk fortifier selected from the group of Nucleotides, Minerals including but not limited to calcium, phosphorous, IgA, IgM, IgG, Lactoferrin, Nucleotides, Linolenic acid and Growth factors alike.

The invention further provides a powdered human milk lipid rich fortifier with a fat component in a quantity ranging from 40 wt/wt % to about 80 wt/wt %, further in where the lipids are derived from human milk and a moisture component in quantity ranging from 1.5 wt/wt % to about 4.5 wt/wt %; and nutrients selected from the group of Nucleotides, Minerals including but not limited to calcium, phosphorous, IgA, IgM, IgG, Lactoferrin, Nucleotides, Linolenic acid and Growth factors alike.

The invention presents an energy rich human milk powder with an energy content in a quantity ranging from 70 cal/100 mL to about 90 cal/100 mL; a moisture component in a quantity ranging from 1.5 wt/wt % to about 4.5 wt/wt %; and nutrients selected from the group of Nucleotides, Minerals including but not limited to calcium, phosphorous, IgA, IgM, IgG, Lactoferrin, Nucleotides, Linolenic acid and Growth factors alike.

Preferably, the freeze dried human milk fortifier is provided in a unit dose container which holds from about in which about 0.5 gm to about 10 gm of said fortifier. The instant invention also relates to a method of providing nutrition to preterm infants by adding a fortifier powder to human milk and administering the fortified human milk to a premature infant. The invention further provides a method of promoting growth of a premature infant by administering fortified human milk to a premature infant.

A method and a composition comprising human milk oligosaccharides for decreasing the production of detrimental proteolytic metabolites such as ammonia and branched chain fatty acids in the intestinal microbiota of humans, which is useful for the treatment of brain-gut disorders like autism, stress, anxiety, and depressive disorders, are disclosed. Methods of treatment of colon cancer and liver damage are also disclosed.

The present invention relates to human milk fortifiers comprising high protein content and long chain poly-unsaturated fatty acids. Use of such human milk fortifier improves the body adipose tissue distribution by increasing the subcutaneous adipose tissue mass, while at the same time not increasing visceral adipose tissue.

A breast shield unit of a breast pump for expressing human breastmilk comprises a breast shield to be placed onto a mother's breast, a breastmilk collection container for receiving expressed breastmilk, an adapter for connecting the breast shield to the breastmilk collection container and a valve head. A breastmilk channel extends from the breast shield into the breastmilk collection container through the adapter and the valve head. The valve head includes a valve which closes and opens the breastmilk channel during the pumping action, wherein a fill level sensor for measuring a fill level of the breastmilk collection container is arranged in the valve head. The breast shield unit according to the invention facilitates a fill level measurement without a structural change of the breast shield and breastmilk collection container. Moreover, it facilitates data interchange with external information storage and/or information processing units.

A nipple-shield mounted sensor with associated electronic interface and interconnect for measurement and display of milk flow and volume during breastfeeding. The sensor is mounted in the tip of the nipple-shield in order to minimise intrusion between mother and child. The sensor can be mounted transverse or parallel to the milk flow in the channel depending on the selected sensing technology. Thedimensions of the sensor and associated cabling are such that the device does not appear substantially different to a nipple-shield alone, thereby having minimal impact on the feeding session. Microlitre flow levels are measured directly by the sensor in order to relay accurate, real-time information on milk volume back to the feeding mother. The electronics unit amplifies the sensor input and digitally processes the data with software algorithms to determine the fluid volume, and can be directly integrated in the shield or can constitute an external module depending on the nature of the sensing technology integrated in the flow channel.